Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study

PURPOSE: Capecitabine, an oral fluorouracil (5-FU) derivative, has replaced 5-FU in many chemotherapy regimens used in various GI tract cancers. The experience with capecitabine in nasopharyngeal carcinoma (NPC) is limited. PATIENTS AND METHODS: We report on eight patients with locally advanced NPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dada, Reyad, El Sayed, Mohamed, Zekri, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646894/
https://www.ncbi.nlm.nih.gov/pubmed/29094083
http://dx.doi.org/10.1200/JGO.2016.006924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646894/
https://www.ncbi.nlm.nih.gov/pubmed/29094083
http://dx.doi.org/10.1200/JGO.2016.006924

Ejemplares similares